inositol has been researched along with Acquired Metabolic Diseases, Brain in 13 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Excerpt | Relevance | Reference |
---|---|---|
"Myoinositol was elevated in the patient with abnormally high serum sodium, and decreased in the hemolytic-uremic syndrome." | 1.30 | 1H MR spectroscopy of the basal ganglia in childhood: a semiquantitative analysis. ( Berry, GT; Bilaniuk, LT; Gibson, J; Haselgrove, JC; Hunter, JV; Kaplan, BS; Kaplan, P; Lam, WW; Wang, ZJ; Zhao, H; Zimmermann, RA, 1998) |
"Despite regional variability of demyelination, proton magnetic resonance spectroscopy revealed a specific metabolic pattern in all patients, with only moderate reduction of N-acetylaspartate, normal or reduced choline-containing compounds, normal or enhanced myo-inositol and no detectable lactate, which differs from findings in progressive cerebral adrenoleukodystrophy which usually exhibits a severe reduction of N-acetylaspartate and marked increases of choline-containing compounds, myo-inositol, and lactate." | 1.29 | Arrested cerebral adrenoleukodystrophy: a clinical and proton magnetic resonance spectroscopy study in three patients. ( Frahm, J; Hanefeld, F; Hunneman, DH; Jost, W; Korenke, GC; Krasemann, E; Pouwels, PJ; Stoeckler, S, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (53.85) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Joers, JM | 1 |
Deelchand, DK | 1 |
Lyu, T | 1 |
Emir, UE | 1 |
Hutter, D | 1 |
Gomez, CM | 1 |
Bushara, KO | 1 |
Eberly, LE | 1 |
Öz, G | 1 |
Ziyeh, S | 1 |
Thiel, T | 2 |
Spreer, J | 1 |
Klisch, J | 1 |
Schumacher, M | 1 |
Viola, A | 1 |
Nicoli, F | 1 |
Denis, B | 1 |
Confort-Gouny, S | 1 |
Le Fur, Y | 1 |
Ranjeva, JP | 1 |
Viout, P | 1 |
Cozzone, PJ | 1 |
Shonk, TK | 1 |
Moats, RA | 1 |
Gifford, P | 1 |
Michaelis, T | 1 |
Mandigo, JC | 1 |
Izumi, J | 1 |
Ross, BD | 1 |
Hanefeld, F | 3 |
Holzbach, U | 1 |
Kruse, B | 1 |
Wilichowski, E | 1 |
Christen, HJ | 2 |
Frahm, J | 3 |
Korenke, GC | 1 |
Pouwels, PJ | 2 |
Hunneman, DH | 1 |
Stoeckler, S | 1 |
Krasemann, E | 1 |
Jost, W | 1 |
Brockmann, K | 1 |
van der Knaap, MS | 1 |
Bakker, HD | 1 |
Valk, J | 1 |
Lam, WW | 1 |
Wang, ZJ | 1 |
Zhao, H | 1 |
Berry, GT | 1 |
Kaplan, P | 1 |
Gibson, J | 1 |
Kaplan, BS | 1 |
Bilaniuk, LT | 1 |
Hunter, JV | 1 |
Haselgrove, JC | 1 |
Zimmermann, RA | 1 |
Laubenberger, J | 1 |
Bayer, S | 1 |
Hennig, J | 1 |
Langer, M | 1 |
Lee, CW | 1 |
Lee, JH | 1 |
Lim, TH | 1 |
Yang, HS | 1 |
Hong, MK | 1 |
Song, JK | 1 |
Park, SW | 1 |
Park, SJ | 1 |
Kim, JJ | 1 |
Khiat, A | 1 |
Yared, Z | 1 |
Bard, C | 1 |
Lacroix, A | 1 |
Boulanger, Y | 1 |
Robertson, NJ | 1 |
Lewis, RH | 1 |
Cowan, FM | 1 |
Allsop, JM | 1 |
Counsell, SJ | 1 |
Edwards, AD | 1 |
Cox, IJ | 1 |
2 trials available for inositol and Acquired Metabolic Diseases, Brain
Article | Year |
---|---|
Probable Alzheimer disease: diagnosis with proton MR spectroscopy.
Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Brain Diseases, Metabolic; Creatine; Dementia; Diagno | 1995 |
Prognostic significance of cerebral metabolic abnormalities in patients with congestive heart failure.
Topics: Adult; Aspartic Acid; Brain; Brain Diseases, Metabolic; Choline; Creatine; Female; Follow-Up Studies | 2001 |
11 other studies available for inositol and Acquired Metabolic Diseases, Brain
Article | Year |
---|---|
Neurochemical abnormalities in premanifest and early spinocerebellar ataxias.
Topics: Activities of Daily Living; Adult; Aged; Aspartic Acid; Ataxins; Brain; Brain Diseases, Metabolic; C | 2018 |
Valproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy.
Topics: Adult; Anticonvulsants; Aspartic Acid; Brain; Brain Diseases, Metabolic; Choline; Creatine; Epilepsy | 2002 |
High cerebral scyllo-inositol: a new marker of brain metabolism disturbances induced by chronic alcoholism.
Topics: Adult; Aged; Alcohol Drinking; Alcoholism; Biomarkers; Brain; Brain Chemistry; Brain Diseases, Metab | 2004 |
Diffuse white matter disease in three children: an encephalopathy with unique features on magnetic resonance imaging and proton magnetic resonance spectroscopy.
Topics: Aspartic Acid; Blood Glucose; Brain; Brain Diseases, Metabolic; Child; Child, Preschool; Choline; Ch | 1993 |
Arrested cerebral adrenoleukodystrophy: a clinical and proton magnetic resonance spectroscopy study in three patients.
Topics: Aspartic Acid; Brain; Brain Diseases, Metabolic; Child; Choline; Demyelinating Diseases; Female; Hum | 1996 |
Localized proton magnetic resonance spectroscopy of cerebral metabolic disturbances in children with neuronal ceroid lipofuscinosis.
Topics: Aspartic Acid; Brain; Brain Diseases, Metabolic; Brain Mapping; Child; Child, Preschool; Choline; Cr | 1996 |
MR imaging and proton spectroscopy in 3-hydroxy-3-methylglutaryl coenzyme A lyase deficiency.
Topics: Amino Acid Metabolism, Inborn Errors; Aspartic Acid; Atrophy; Brain; Brain Diseases, Metabolic; Chil | 1998 |
1H MR spectroscopy of the basal ganglia in childhood: a semiquantitative analysis.
Topics: Adolescent; Adult; Aspartic Acid; Basal Ganglia; Basal Ganglia Diseases; Brain Diseases, Metabolic; | 1998 |
[Clinical uses of proton magnetic resonance spectroscopy of the brain].
Topics: AIDS Dementia Complex; Alzheimer Disease; Animals; Aspartic Acid; Brain; Brain Diseases; Brain Disea | 1998 |
Long-term brain metabolic alterations in exogenous Cushing's syndrome as monitored by proton magnetic resonance spectroscopy.
Topics: Adult; Aspartic Acid; Brain; Brain Diseases, Metabolic; Brain Injuries; Cell Membrane; Choline; Crea | 2001 |
Early increases in brain myo-inositol measured by proton magnetic resonance spectroscopy in term infants with neonatal encephalopathy.
Topics: Apgar Score; Brain; Brain Diseases, Metabolic; Creatinine; Gestational Age; Humans; Infant, Newborn; | 2001 |